-
November 1: The Week in Cancer News
Long-term monitoring can catch side effects in childhood cancer survivors, and breast cancer screening rates remain low among transgender people.
by Thomas Celona
-
October 25: The Week in Cancer News
Asian American and Pacific Islander women face rising rates of early-onset breast cancer, and the risk for dying of COVID-19 is twice as high in people living with cancer.
by Eric Fitzsimmons
-
October 18: The Week in Cancer News
Immunotherapy lowers risk of side effects in advanced lymphoma, and an extra course of chemotherapy improves survival in cervical cancer.
by Marci A. Landsmann
-
October 11: The Week in Cancer News
Expanded dependent coverage improves cancer outcomes in young adults, and breast cancer treatment can lead to faster cell aging.
by Kevin McLaughlin
-
October 4: The Week in Cancer News
Study finds people who receive brain radiation often recover cognitive abilities over time, and report details breast cancer trends.
by Thomas Celona
-
September 27: The Week in Cancer News
Adding MRI to prostate screening can help limit overdiagnosis, and breast cancer patients who smoke have a higher risk of radiotherapy-related lung cancer.
by Eric Fitzsimmons
-
September 20: The Week in Cancer News
The AACR spotlights cancer advances and challenges in new report, and the FDA approves second CDK 4/6 inhibitor to reduce risk of recurrence in early-stage breast cancer.
by Marci A. Landsmann
-
September 13: The Week in Cancer News
Mammogram findings will now include information about breast density, and youth vaping is on the decline.
by Kevin McLaughlin
-
September 6: The Week in Cancer News
Asian American and Pacific Islander women experience rising breast cancer incidence, and a study finds most people diagnosed with cancer will experience cognitive symptoms.
by Thomas Celona
-
August 30: The Week in Cancer News
Access to high-quality hospitals may be affected by insurance type, and the proliferation of digital tools could increase burdens on patients.
by Eric Fitzsimmons
Cancer Talk
Can Steroids Impair Immunotherapy for Cancer?
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona